Filter posts

Managed Entry Trumps Risk Sharing

Since 2000, pharmaceu-tical and biotech companies have engaged in agreements with government and private payers …

Ernst & Young's Beyond Borders: Matters of Evidence

Hundreds of attendees turned out to glean insights from findings outlined in Ernst & Young …

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, …

Governors Share Best Practices on Bringing Biotech Jobs to their States

With the state competition for biotech jobs in full force at the BIO International Convention, …

AquAdvantage Salmon: A Regulatory Odyssey

At BIO 2012, an article was published on AquaBounty Technologies which told the tale of …

Alzheimer’s Disease “Robs You of Everything”

George Hendrick and his wife, Mary Lee, experienced the typical highs and lows of parenthood …

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s …

Biomedical R&D in the 21st Century

Reflecting back upon my career,  I recognize the importance academic-industry research partnerships played in shaping …

#BIO 2013: Open Innovation and Biopharmaceutical R&D

In these changing times, the concept of Open Innovation is one that we at AstraZeneca …

Natalie Ng wins the International BioGENEius Challenge

Today, Cupertino Junior Natalie Ng won the International BioGENEius Challenge, the premier competition for high …